About Synthematix
Synthematix is a Healthcare company based in Durham (United States) founded in 2000, and was acquired by Symyx Technologies in February 2005. Synthematix develops organic synthesis reaction planning software for pharmaceutical and biotechnology industries. Synthematix offers products and services including ELISA Kits, PCR Kits, Antibodies, and Assay Kits. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Insitro, HotSpot Therapeutics and Certara; 2 of its 3 listed competitors have raised funding.
Company details
Synthematix was founded in 2000 in Durham, United States, focusing on software for organic synthesis in pharmaceutical and biotechnology sectors. ARTHUR, a suite of tools for synthetic chemistry planning, is offered alongside StructureSearch, a substructure search development kit. Deployment services, including installation, training, integration, custom development, and experimental data capture, are provided to support operations.
- Headquarters Durham, United States
- Stage Acquired
- SectorsHealthcare
- Website synthematix.com
- Social LinkedIn
- Acquired by Symyx Technologies (Feb 2005)
- Investors
- Acquired bySymyx Technologies
(Feb 2005)
Products & Services of Synthematix
Synthematix offers a comprehensive portfolio of products and services, including ELISA Kits, PCR Kits, Antibodies, and Assay Kits.
Kits for detecting proteins and antibodies in research
Tools for DNA amplification and analysis
Reagents used for immune response studies
Kits for biochemical assays and metabolic analysis
Investors in Synthematix
Synthematix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Symyx Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Informatics and automation products for research are offered. | 1994 | symyx.com | San Diego, United States |
Investor details for Synthematix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Synthematix
2 dated milestones of Synthematix across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Synthematix is founded.
- Exit Acquired by Symyx Technologies.
Competitors of Synthematix
Synthematix has 3 listed competitors in our database, 2 of them funded. They include Insitro, HotSpot Therapeutics and Certara.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| hotspotthera.com | 2017 | Boston, United States | $210M | 37 | Developer of a platform for protein function analysis | |
| certara.com | 2008 | Princeton, United States | 827 | Provider of a platform for in silico drug discovery and consulting services |
Detailed competitors of Synthematix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Synthematix (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synthematix
Synthematix was founded in 2000.
Synthematix is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Synthematix was founded in 2000 in Durham, United States, focusing on software for organic synthesis in pharmaceutical and biotechnology sectors. ARTHUR, a suite of tools for synthetic chemistry planning, is offered alongside StructureSearch, a substructure search development kit. Deployment services, including installation, training, integration, custom development, and experimental data capture, are provided to support operations.
Synthematix's top competitors include Insitro, HotSpot Therapeutics and Certara.
Synthematix offers ELISA Kits, PCR Kits, Antibodies, and Assay Kits.
Synthematix has 1 investor. Key investors include Symyx Technologies.
Yes. Synthematix was acquired by Symyx Technologies in February 2005.